richard kim, md determines whether checkpoint inhibitors combine with regorafenib for hcc treatment
Published 4 years ago • 31 plays • Length 1:47
Download video MP4
Download video MP3
Similar videos
-
1:14
richard kim, md, regarding the use of regorafenib in treatment of colorectal cancer
-
1:26
richard kim, md, offers opinion on the redos study and dose escalation of regorafenib
-
1:34
richard kim, md, on the use and sequencing of tkis in hepatocellular carcinoma (hcc)
-
6:31
what are checkpoint inhibitors?
-
1:14
richard kim, md, discusses pembrolizumab as an effective agent in hcc management
-
3:41
a physician faces stage iv #kidneycancer: his advice for you
-
9:46
殺死癌細胞、逆轉癌症千萬不要忘記這個方法 how to reverse cancer? @grandhealth
-
19:56
danny hillis: understanding cancer through proteomics
-
2:17
richard finn, md, speculates on combined checkpoint inhibition in hcc & biliary tract cancer
-
1:17
richard kim, md, shares how we can utilize tkis in the management of hepatocellular carcinoma
-
0:58
dr. kim reviews studies investigating regorafenib in mcrc
-
3:11
hepatobiliary surgery
-
1:24:27
the renal pathology of check point inhibitors
-
0:47
dr. richards on parp inhibition in pancreatic cancer
-
7:10
evidence with checkpoint inhibition in hcc
-
1:18
dr. richard kim on administering aflibercept in colorectal cancer
-
1:47
dustin a. carlson, md
-
1:04:19
implementing pbm in a resource limited setting: what, where, when, how and who? - dr claire barrett
-
7:57
kynurenine/tryptophan is associated with biomarkers of neurodegenerative disease
-
3:26
revolutionising breast cancer screening: the power of ai
-
0:57
dr. richards on using parp inhibitors in mutated metastatic pancreatic cancer
-
7:15
our four pillars of cancer immunology research
Clip.africa.com - Privacy-policy